Literature DB >> 6441736

Tyrosinase-like activity in normal human substantia nigra.

M Miranda, D Botti, A Bonfigli, T Ventura, A Arcadi.   

Abstract

A tyrosinase-like activity was found in human substantia nigra by polyacrylamide gel electrophoresis of fractions prepared from homogenates of the substantia nigra. The enzyme activity was detected by staining the gels with L-3,4-dihydroxyphenylalanine, dopamine and 5,6-dihydroxyindole as substrates for tyrosinase (EC 1.14.18.1). A case of parkinsonism does not show the L-3,4-dihydroxyphenylalanine and dopamine oxidase activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441736     DOI: 10.1016/0306-3623(84)90212-x

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  18 in total

1.  Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase.

Authors:  M Rios; B Habecker; T Sasaoka; G Eisenhofer; H Tian; S Landis; D Chikaraishi; S Roffler-Tarlov
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

Review 2.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

3.  2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin.

Authors:  P A Rosenberg; R Loring; Y Xie; V Zaleskas; E Aizenman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification.

Authors:  F Solano; V J Hearing; J C García-Borrón
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

Review 5.  Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.

Authors:  Masato Asanuma; Ikuko Miyazaki; Norio Ogawa
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 6.  Olive Oil Polyphenols in Neurodegenerative Pathologies.

Authors:  Constantinos Salis; Louis Papageorgiou; Eleni Papakonstantinou; Marianna Hagidimitriou; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 7.  Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson's disease.

Authors:  Takafumi Hasegawa
Journal:  Int J Mol Sci       Date:  2010-03-12       Impact factor: 5.923

8.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

9.  Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments.

Authors:  Vivek Lawana; Se Young Um; Rachel M Foguth; Jason R Cannon
Journal:  Neurotoxicology       Date:  2020-10-13       Impact factor: 4.294

10.  Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Amanda Platten; Leia Pitcher; Jana Goins; Pamela P Auerbach
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.